CBIZ, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated November 1, 2024, announces the completion of a major strategic transaction by CBIZ, Inc. (the "Company"). On this date, the Company closed an Agreement and Plan of Merger entered into on July 30, 2024, with Marcum LLP ("Marcum"). The transaction involves the acquisition of Marcum's non-attest business assets, while Marcum's attest business assets were purchased separately by CBIZ CPAs P.C.
Key Financial Metrics and Transaction Details
The filing details significant capital deployment and financing activities related to the acquisition:
- Total Cash Consideration: The Company paid $637.6 million in cash to Marcum partners (subject to adjustments and escrow) and an additional $425.5 million to satisfy Marcum obligations and closing payments, totaling approximately $1.063 billion in cash outflows at closing.
- Equity Consideration: The Company will issue 14,260,645 shares of common stock to Marcum partners. Delivery is structured as follows: 713,032 shares subject to service requirements (delivered in 4 years), 2,852,129 shares on January 2, 2025, and the remaining 10,695,484 shares in 36 monthly installments starting January 2, 2025.
- Debt Financing: To fund the transaction, the Company entered into new senior secured credit facilities totaling $2.0 billion, consisting of a $1.4 billion term loan and a $600 million revolving credit facility.
- Debt Maturity and Terms: The new facilities mature on November 1, 2029. The term loan requires principal amortization of 5% annually for the first two years, 7.5% for the third and fourth years, and 10% in the fifth year.
- Covenants: The credit agreement includes a Total Net Leverage Ratio (TNLR) covenant not to exceed 5.00 to 1.00 initially, stepping down to 3.75 to 1.00. A Minimum Consolidated Interest Coverage Ratio of 3.00 to 1.00 is also required.
Note: This filing does not provide consolidated revenue, profit, or cash flow metrics for CBIZ, Inc. for a specific reporting period. It focuses exclusively on the transaction mechanics and financing.
Material Changes Versus Prior Period
The primary material change is the structural expansion of the Company through the acquisition of Marcum's non-attest business. This represents a significant increase in the Company's asset base and debt load compared to the prior period. The Company has replaced its prior credit facility (dated May 4, 2022) with the new $2.0 billion facility to support this growth.
Guidance, Outlook, and Risks
- Board Composition: The Merger Agreement grants Marcum the right to nominate a director to the Company's board, with an expected appointment in early 2025.
- Pro Forma Information: The Company intends to file pro forma financial information regarding the transaction within 71 calendar days of this report.
- Risks and Contingencies: The cash consideration is subject to customary post-closing adjustments. The Company is now subject to the financial covenants of the new credit agreement, including leverage and interest coverage ratios. The equity portion of the deal involves a multi-year vesting schedule, creating future dilution.
Key Facts for Investor Verification
- Verify the final purchase price adjustments and the exact amount of cash consideration paid after escrow releases.
- Monitor the upcoming pro forma financial statements to understand the combined entity's leverage and earnings power.
- Track the issuance of the 14.26 million shares of common stock and the associated dilution impact on existing shareholders.
- Review the Company's ability to meet the new Total Net Leverage Ratio covenant of 5.00 to 1.00 in the immediate post-closing period.
- Confirm the appointment of the Marcum-nominated director to the Board of Directors in early 2025.